Loretta Jophlin, MD
Gastroenterology · Louisville, KYNPI 1477852101
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,200 of the $6,288 with a category attached, or 82.7%. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 93.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $5,747, more than ten times the $363 reported in 2021.
Across 18 payments — averaging $349.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$6K
- AbbVie$179
- E.r. Squibb & Sons, L.L.C.$122
- Mirum Pharmaceuticals, Inc.$90
- Intercept Pharmaceuticals, Inc.$30
- Conmed Corporation$18
Across 44 payments — averaging $3814.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$80K
- Bausch Health US, LLC$52K
- Bristol Myers Squibb$36K
What the payments were for
- Speaking & faculty fees$5,20083%
- Travel & lodging$1613%
- Food & beverage$92715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $5,848 |
| AbbVie | 2 | $179 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Mirum Pharmaceuticals, Inc. | 1 | $90 |
| Intercept Pharmaceuticals, Inc. | 1 | $30 |
| Conmed Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,288 in reported general payments places this provider in the 65th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Everolimus | 64 | $91,297 |
| XifaxanRifaximin | 25 | $83,157 |
| Envarsus XrTacrolimus | 42 | $46,699 |
| Tacrolimus | 140 | $23,476 |
| Mycophenolic AcidMycophenolate Sodium | 37 | $19,385 |
| Sirolimus | 24 | $14,246 |
| Mycophenolate Mofetil | 79 | $8,380 |
| Ursodiol | 44 | $6,152 |
| Cyclosporine ModifiedCyclosporine, Modified | 24 | $3,210 |
| Lamivudine HbvLamivudine | 13 | $1,851 |
| Tenofovir Disoproxil Fumarate | 15 | $1,679 |
| Mesalamine ErMesalamine | 13 | $737 |
| Pantoprazole Sodium | 40 | $594 |
| Prednisone | 51 | $412 |
| Baclofen | 27 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $5,848 | $83,15725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 207 gastroenterology providers in Kentucky.
Other gastroenterology in Louisville
- Gerald DrydenLouisville$2.1M
- Matthew CaveLouisville$340K
- Michael KreaseLouisville$322K
- Sunana SohiLouisville$220K
- Jeffrey TuvlinLouisville$202K
- Stephen McClaveLouisville$124K
- Ashutosh BarveLouisville$43K
- Thomas AbellLouisville$36K
- Nanlong LiuLouisville$31K
- Craig McClainLouisville$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.